Clinical Trials in Progress: Prostate Cancer
Sunday, May 17, 2026 1:00 PM to 3:00 PM · 2 hr. (America/New_York)
Hall B, The Square, Learning Lab
Learning Lab
New Technologies/Instruments/DevicesOncology: Prostate
Information
Of Interest To
Researchers
Sunday, May 17
A Phase 3 Trial of the Androgen Receptor Ligand-directed Degrader BMS-986365 Versus Investigator’s Choice in Patients with Metastatic Castration-resistant Prostate Cancer (CA071-1000 – rechARge)
Sunday, May 17, 2026 1:00 PM to 1:08 PM
Hall B, The Square, Learning Lab
A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen)
Sunday, May 17, 2026 1:08 PM to 1:16 PM
Hall B, The Square, Learning Lab
Artificial Intelligence–Assisted Multiparametric Ultrasound (PCaVision) versus MRI for Prostate Cancer Detection: A European Multicenter Prospective Paired Non-Inferiority Study
Sunday, May 17, 2026 1:16 PM to 1:24 PM
Hall B, The Square, Learning Lab
Phase 3 study of 68Ga-PSMA-11 PET combined with MRI for the detection of prostate cancer (BIPASS)
Sunday, May 17, 2026 1:24 PM to 1:32 PM
Hall B, The Square, Learning Lab
The BeSpoke Decision Support Decision Aid for Patients with Newly Diagnosed Localised Prostate Cancer – A Single-blind Randomised Controlled Trial
Sunday, May 17, 2026 1:32 PM to 1:40 PM
Hall B, The Square, Learning Lab
Evaluation of PSMA PET-CT in Active Surveillance for Prostate Cancer (ESCAPE): A Prospective, Multi-Institutional Diagnostic Study
Sunday, May 17, 2026 1:40 PM to 1:48 PM
Hall B, The Square, Learning Lab
68Ga-P16-093 PSMA PET-CT–Guided Surgical Planning for Radical Prostatectomy: A Phase II Randomized Clinical Trial
Sunday, May 17, 2026 1:48 PM to 1:56 PM
Hall B, The Square, Learning Lab
Vanquish® Water Vapor Ablation for PrOstate CanceR (VAPOR 2 Study)
Sunday, May 17, 2026 1:56 PM to 2:04 PM
Hall B, The Square, Learning Lab
Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment
Sunday, May 17, 2026 2:04 PM to 2:12 PM
Hall B, The Square, Learning Lab
IRRADIANT: Irreversible Electroporation versus Radiation Boost for Intermediate Risk Prostate Cancer
Sunday, May 17, 2026 2:12 PM to 2:20 PM
Hall B, The Square, Learning Lab
The clinical effectiveness of PSMA PET-CT-only defined and escalated treatment compared to conventional imaging for high-risk prostate cancer: a double-blind, multicentre, randomised controlled trial (IP10-AVIDITY)
Sunday, May 17, 2026 2:20 PM to 2:28 PM
Hall B, The Square, Learning Lab
ARID II: Pivotal Study of a Urologic Scaffold for the Treatment of Post Prostatectomy Stress Urinary Incontinence
Sunday, May 17, 2026 2:28 PM to 2:36 PM
Hall B, The Square, Learning Lab
AMPLIFY: A Phase 3 Study of 64Cu-SAR-bisPSMA Positron Emission Tomography in Participants with Biochemical Recurrence of Prostate Cancer
Sunday, May 17, 2026 2:36 PM to 2:44 PM
Hall B, The Square, Learning Lab
Biochemical Recurrence Irradiation versus Observation (BRIO) in Prostate Cancer Patients: Protocol for a Phase III Randomized Control Trial
Sunday, May 17, 2026 2:44 PM to 2:52 PM
Hall B, The Square, Learning Lab
OMAHA-004: Phase 3 trial of the steroidogenesis inhibitor opevesostat versus androgen receptor pathway inhibitor (ARPI) switch in participants with metastatic castration-resistant prostate cancer after a prior ARPI
Sunday, May 17, 2026 2:52 PM to 3:00 PM
Hall B, The Square, Learning Lab